EGFR and non-small cell lung carcinoma: Song et al demonstrated that dasatinib induces apoptosis in a number of NSCLC cells that exhibit a mutant EGFR phenotype; however, this effect was not observed in NSCLC cell lines with a wild-type EGFR phenotype [9].